Skip to main content
. 2017 Oct 25;8(55):94893–94899. doi: 10.18632/oncotarget.22046

Table 3. Treatment of hyperuricemia.

BMI <25 kg/m2 (n=1296) BMI ≥25 kg/m2 (n=3382) P-value
Use of allopirunol, n 379(29.2) 2031(60.1) <0.05
Use of febuxostat, n 82(6.3) 189(5.6) >0.05
Use of benzbromarone, n 367(28.3) 228(6.7) <0.05
Use of combination urate-lowering therapies, n 35(2.7) 577(17.1) <0.05
Lifestyle intervention only, n 433(33.4) 357(10.6) <0.05